logo
Rentable E-Scooter Injuries an Increasing Burden in Edmonton

Rentable E-Scooter Injuries an Increasing Burden in Edmonton

Medscape05-05-2025

Rental electric scooter (e-scooter) injuries among adults are increasingly common in a large Canadian city. Men and women are presenting to emergency departments (EDs) in Edmonton with multiple injuries that represent 'substantial burdens' to patients and the Canadian healthcare system, a new analysis suggested.
Most e-scooter use in Edmonton involves rentals, as the use of privately owned e-scooters on city property is prohibited.
'We were surprised by the high percentage of ambulance use (20%), as well as the required post-ED visit follow-up, with 30% of patients requiring further follow-up and almost 10% of patients requiring surgery within 30 days of presenting to an ED following an e-scooter injury,' lead author Erin Bristow, MD, an emergency medicine doctor at University of Alberta Hospital, Edmonton, told Medscape Medical News .
Erin Bristow, MD
'The incidence of head injuries was notable (17%), as was the high rate of fractures (32%) among the patients studied,' she said.
The study was published on April 17 in the Canadian Journal of Surgery .
Multiple Injuries Common
To determine the incidence and severity of injuries from rentable e-scooters among adults presenting to Edmonton EDs, researchers investigated 759 e-scooter–related injury presentations during three summer seasons (2019-2021).
The patients' median age was 28 years. Men and women were almost equally represented. About 20% of patients presented by ambulance, and 14% were triaged as urgent.
Most patients (61.5%) had multiple injuries, and fractures (31.9%) and head injuries (17%) were common.
Helmet use was rare (2.4%), but concomitant substance use was common (26.4%). Most patients (76.3%) underwent investigations during their ED visit, and 11% required a consulting service while in the ED.
Only 5.5% of patients were admitted to the hospital, but 30% required further follow-up. This group included 9.1% of patients requiring surgery within 30 days of their primary visit to an ED, 10.3% of patients re-presenting to an ED, and 9.7% requiring a formal outpatient follow-up visit.
No deaths were documented during the study period.
The study was limited by its focus on rental e-scooter injuries among adults, which excluded pediatric injuries. Moreover, the catchment population was in a single municipality, potentially limiting the generalizability of the results. In addition, the prevalence of e-scooter injuries could have been underestimated due to missing triage text or inadequate chart coding.
'This is not a benign activity,' Bristow noted. Potential preventive strategies could include mandatory helmet regulations, e-scooter speed restrictions beyond the current local restriction of 20 km/h, and user education regarding the risks of e-scooter use while intoxicated, she suggested.
Clinicians can help by providing patient education in the ED and in the office and by advocating for injury prevention strategies to be implemented by municipalities that license the use of rentable e-scooters, she added.
'Small, Attractive, Popular'
Donald Redelmeier, MD, the Canada Research Chair in Medical Decision Sciences and a professor of medicine at the University of Toronto, Toronto, said that the findings are typical of his experience as a physician in the trauma center at Sunnybrook Health Sciences Centre, Toronto.
Donald Redelmeier, MD
More injuries are occurring, at least in part because e-scooters are a relatively new technology, he told Medscape Medical News . 'In the same way that we're seeing fewer patients with injuries from falling off a horse, we're bound to see more injuries from patients falling off of e-scooters, especially since the wheels are small, the base of support is extremely narrow, and users are often unfamiliar with the device.'
The authors did not mention the fire hazard associated with the batteries, which have led some cities to ban all forms of e-scooters, he noted. Nor did they mention the potential collateral damage to pedestrians who are sometimes knocked over in a collision with an e-scooter.
Regarding preventive strategies, he said, 'Education is super important. You just can't outlaw these things. They're too small and attractive and popular. And there's inevitably a balance between safety and freedom.'
Like Bristow, Redelmeier highlighted the importance of protective gear. 'The fact that less than 10% of these individuals were wearing a helmet is a solvable problem that should be enforced. So, you don't prohibit the technology, but you do make some requirement about mandatory helmets, as is the case in other parts of Canada, like Ontario.'
Furthermore, protective gear involves more than helmets, he said. 'Gloves and proper footwear help a lot. The adage says that it's better to sweat than to bleed, and this study certainly shows that there are a lot of superficial injuries, very commonly to the elbows and the hands, that could have been prevented easily with gloves and maybe elbow guards that are quite inexpensive.'
The study did not examine why the patients fell off their scooters in the first place, and that's common, he said. 'That also applies for people who get injured on their bicycles, on their motorcycles, and in other motor vehicles.
'One of the profound lessons about motor vehicle travel is that often you don't know why the misadventure occurred, either because of associated amnesia or because the incident occurs so quickly that you have no idea why you ended up on the ground,' he said. 'Ergo, you have no real way of learning from your past experiences to prevent it from happening in the future. And that's why proactive forms of education are so important because you just can't learn until it's too late.'
This research received in-kind support from the Emergency Medicine Research Group in the Department of Emergency Medicine, Faculty of Medicine and Dentistry, College of Health Sciences at the University of Alberta. It also received financial support from a Scientific Director's Grant from the Canadian Institutes of Health Research to support data access, data extraction, database management, and statistical analysis. Finally, the project received financial support from the City of Edmonton and the Injury Prevention Centre at the University of Alberta. Bristow and Redelmeier reported having no relevant financial relationships.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR PROLONGED GRIEF DISORDER
FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR PROLONGED GRIEF DISORDER

Yahoo

time27 minutes ago

  • Yahoo

FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR PROLONGED GRIEF DISORDER

The clinical trial at Linkoping University will study Filament's botanical psilocybin drug candidate, PEX010 VANCOUVER, BC, June 11, 2025 /CNW/ - Filament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that the Swedish Ethical Review Authority and the Swedish Medical Products Agency have authorized a double-blind phase 2 clinical trial studying its botanical psilocybin drug candidate, PEX010, at Linkoping University. The trial will be the first to study the effects of psilocybin in the treatment of prolonged grief disorder. "In an aging society where people may outlive their family members by decades, it is crucial to develop treatment options for those with prolonged grief disorder," said Dr. Rebecca Böhme, Associate Professor at the Linkoping Center for Social and Affective Neuroscience. "This trial will assess whether psilocybin can improve adaptation to the loss experience. We are grateful to Filament Health for facilitating this research." People with prolonged grief disorder are at a 20 percent increased mortality risk. Previous psychological research suggests that the loss of a close person affects self-identity, an aspect of the higher cognitive self. Psilocybin is suggested to cause a transient shift from reliance on prior experiences towards current sensations. The clinical trial at Linkoping University will utilize this shift combined with a self-touch intervention to support re-learning about the bodily self in a trial population of 120 individuals. "We're pleased to provide PEX010 to Linkoping University for this much-needed area of research," said Benjamin Lightburn, Co-Founder and Chief Executive Officer at Filament Health. "This will be the ninth European clinical trial to study our drug candidate, positioning Filament as the region's leading supplier of GMP psilocybin." The trial at Linkoping University is expected to begin dosing in Q3 2025. PEX010 is authorized for investigation in 52 clinical trials worldwide for 14 mental health indications. ABOUT FILAMENT HEALTH (OTC:FLHLF)Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates. Learn more at and on Twitter, Instagram, and LinkedIn. FORWARD LOOKING INFORMATIONCertain statements and information contained in this press release and the documents referred to herein may constitute "forward‐looking statements" and "forward‐looking information," respectively, under Canadian securities legislation. Generally, forward‐looking information can be identified by the use of forward‐looking terminology such as, "expect", "anticipate", "continue", "estimate", "may", "will", "should", "believe", "intends", "forecast", "plans", "guidance" and similar expressions are intended to identify forward‐looking statements or information. The forward‐looking statements are not historical facts, but reflect the current expectations of management of Filament regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward‐looking statements. Forward‐looking statements regarding the Company are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of Filament to be materially different from those expressed or implied by such forward‐looking statements or forward‐looking information, including the timing and results of clinical trials, the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the proposed business combination; other expectations and assumptions concerning the transactions contemplated in the proposed business combination; the available funds of the parties and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the psychedelic drug development industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the psychedelic drug development industry; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; and risks related to future acquisitions or dispositions. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward‐ looking statements and forward‐looking information. Filament will not update any forward‐looking statements or forward‐looking information that are incorporated by reference herein, except as required by applicable securities laws. SOURCE Filament Health Corp. View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Research cuts pose ‘existential threat' to academic medicine and put nation's health at risk, new report says
Research cuts pose ‘existential threat' to academic medicine and put nation's health at risk, new report says

Yahoo

time36 minutes ago

  • Yahoo

Research cuts pose ‘existential threat' to academic medicine and put nation's health at risk, new report says

Federal research funding cuts pose an 'existential threat' to academic medicine that will have repercussions for patient care in the US, according to a new report from the Association of American Medical Colleges, highlighting what it calls significant damage already done to the nation. The association, which represents 172 MD-granting US and Canadian medical schools and more than 490 teaching hospitals and health systems, noted in Wednesday's report that proposals in the House GOP tax and spending cuts bill could lead to a loss of health insurance for 11 million people enrolled in Medicaid or Affordable Care Act coverage and jeopardize loans for half of medical students. This is the first time in recent history when all three missions of academic medicine – research, education and patient care – are threatened, said Heather Pierce, the association's senior director for science policy. Typically, she said, when one is under fire, the others can compensate to ensure that health care is not compromised. 'This is the first time that all the missions of academic medicine simultaneously face these threats from our federal partners,' Pierce said. Should this trend continue, Pierce said, the United States will probably face a physician shortage, stagnation in scientific progress and a decline in the quality of medical care. Academic health systems, which include medical schools and teaching hospitals, educate future physicians and investigate complex medical cases, treating the sickest patients. The new report says these institutions are also twice as likely as other hospitals to provide clinical services such as trauma centers, organ transplant centers, birthing rooms and substance use disorder care. The report says patients treated at major teaching hospitals – where future health care professionals receive practical hands-on training – have up to 20% higher odds of survival than those treated at non-teaching hospitals. Funding cuts to these institutions have effects that trickle down to patients nationwide. The report noted that academic health systems conduct the majority of research funded by the US National Institutes of Health, and complex patient care is made possible only through extensive medical research. As of June, more than 1,100 NIH grants have been terminated since the beginning of the second Trump administration, according to the report. These include at least 160 clinical trials to study HIV/AIDS, cancer, mental health conditions, substance abuse and chronic disease. Although not all clinical trials involve life-saving treatments, for some people who have diseases that have no established therapies, trials may be their only option. 'We've made terrific progress in many diseases, but there are many diseases where we have a long way to go to be able to offer a newly developed treatment that we know can improve or lengthen their lives,' Pierce said. 'With those diseases, in many cases, the only way to try to move forward is with what scientists think are the very best potential treatments for those diseases.' Some of the clinical trials were terminated before their conclusion, which is unethical, she said. 'Halting a clinical trial before it ends at any point, even if all of the patients who are in the clinical trial finish their treatment, before data analysis has been done, before the results are released, renders that clinical trial less useful and less ethical,' she said. Patients take on the risk of uncertainty when they join clinical trials, not knowing whether the treatment will be effective. 'If we never know the outcome, all of that time, all those patients launching everything that they did to bring science forward has been wasted. In some cases, it could be years of progress.' The report notes that research funding has made crucial contributions to life-saving care. For example, the NIH funded the development of the first artificial heart valve with the first successful replacement at the NIH Clinical Center in 1960. Today, more than 100,000 heart valve replacements are performed each year. And a study also found that NIH funding contributed to research associated with every new drug approved from 2010 to 2019. Each year, medical schools and teaching hospitals that are members of the Association of American Medical Colleges train about 77,000 residents nationwide, making these institutions the primary producers of primary care and specialty physicians. Medicare offsets a portion of the costs for the majority of trainees, and teaching hospitals fully cover the cost of training for the rest of the residents. The proposed elimination of federal student aid programs and changing eligibility requirements for loan forgiveness would affect nearly half of all medical students, the new report says. Should investment not increase, the association predicts that the nation will face a shortage of up to 86,000 physicians by 2036. As federal partnerships with research institutions continue to falter and immigration restrictions become more strict, the United States is becoming a less attractive place for students to pursue science, Pierce said. The nation has benefited from their longstanding global medical and scientific approach, she said. 'There is information being shared between countries, people being trained all over the world,' Pierce said. 'The United States has always been the place where people want to come, trained to be scientists and trained to be physicians, and we have benefited from that.' Nearly half of US graduate students in STEM fields are from other countries. If the United States is not seen as a place that will collaborate with and welcome international scholars, students and researchers will leave, Pierce said. She emphasizes that what makes US innovation unique is that research comes 'with not the support but the full partnership of the federal government.' A weakening of this partnership will make it 'harder for the United States to stay as the driver of innovation and science progress,' Pierce said. A physician shortage coupled with declining research investment leads to the suffering of patient care, she said. 'When the research stops, progress stops,' Pierce said. 'Scientific progress toward more treatment, towards more cures, towards a better quality of life, is all dependent on this ecosystem [of academic medicine] that is more intertwined than I think anyone realized.'

Rocky Health and the Toronto Argonauts Team Up to Tackle Stigma Around Men's Health
Rocky Health and the Toronto Argonauts Team Up to Tackle Stigma Around Men's Health

Yahoo

time2 hours ago

  • Yahoo

Rocky Health and the Toronto Argonauts Team Up to Tackle Stigma Around Men's Health

The partnership marks Rocky Health's third collaboration with a national sports organization, reinforcing its growing influence in the sports industry and its commitment to supporting men's health TORONTO, June 11, 2025 /CNW/ - Today, Rocky Health, Canada's modern digital men's health and wellness platform, is thrilled to announce a new multi-year partnership with the Toronto Argonauts, bringing the conversation around men's health to centre field. In partnership with the most legendary franchise in Canadian football, Rocky Health is showcasing its commitment to redefining how men take ownership of their health. To connect with Canadian men and challenge outdated health stigmas, Rocky Health is showing up where they are, within major sports leagues and at the heart of the game. This latest announcement builds on a series of recent partnerships with leading Canadian sports organizations, as Rocky Health continues to strengthen its presence across the sports industry and meet men where they already are. "At Rocky Health, we're committed to partnering with organizations with like-minded values, especially when it comes to prioritizing health and the importance of showing up for the people who matter most. We believe taking care of your health means taking care of those around you too," says Aba Anton, Co-Founder & CEO of Rocky Health. "Our partnership with the Toronto Argonauts is about using the power of sport to meet men where they are and redefine what strength truly means, not just in physical performance, but in showing up for yourself and those around you. It's about being proactive, having the courage to talk about what matters, and recognizing the role that family, teammates, and friends play in supporting one another on and off the field." Rocky Health will be front and centre all season long, starting with the jersey patch worn by the defending Grey Cup champions. The partnership includes a goal post wrap, digital signage throughout the grandstands, virtual field placements, and displays in and around BMO Field. On game days, Rocky Health will also be featured on the Argos' social media channels, with integration of organic team content. Fans on social media can enter to win signed jerseys and premium tickets via Rocky Health's channels. "This exciting new partnership brings together a progressive, young company with one of the country's oldest and most successful sports traditions, working to bring attention to a priority for us all, men's health," says Keith Pelley, President & CEO, Maple Leaf Sports & Entertainment. "We look forward to the impact of this partnership with Rocky Health being felt with the team's fans and in the community for years to come." Through this partnership, Rocky Health is tackling the everyday barriers that often prevent men from seeking care, from long wait times and disconnected services to the outdated belief that asking for help is a sign of weakness. The Rocky Health platform brings clinical care, pharmacy support, and wellness tools together in one seamless digital experience–designed to meet men where they are, no clinic or pharmacy waiting rooms required. The partnership has been met with enthusiasm by both organizations, highlighting a shared commitment to driving meaningful change in the conversation around men's health. "The Toronto Argonauts are proud to partner with Rocky Health on a mission that goes far beyond the field," says Argos President, Michael 'Pinball' Clemens. "Our team is built on brotherhood, resilience, and showing up for one another, which are all values that align with Rocky Health's vision for better men's health. Together, we're encouraging our fans–fathers, sons, brothers, and teammates–to take that crucial first step toward care, conversation, and lasting change." As the Official Men's Health Provider of the Toronto Argonauts and the team's jersey patch partner, Rocky Health is proud to be a key partner of the team, bringing modern, stigma-free care to fans across the country. With on-field visibility at this season's home opener on June 14th and activations planned throughout the year, Rocky Health and the Toronto Argonauts unite in their commitment to champion men's health, whether in the stands, in the locker room, or watching the game at home. About Rocky HealthRocky Health was founded in Toronto by three childhood friends. After finding success in their healthcare fields, and personally experiencing gaps in the healthcare system, they were inspired to launch Rocky Health in 2021. The founding team comprises Chief Medical Officer, Dr. George Mankaryous, M.D. CCFP, Chief Pharmaceutical Officer, Mina Rizk, MPharm and Chief Executive Officer, Aba Anton, MPharm. Rocky Health owns its medical clinic, which employs a full-time staff of healthcare professionals, and its OCP-accredited pharmacy, which dispenses and ships medication to provide a seamless user experience. Mental health, sexual health, weight loss, hair loss and smoking cessation services are currently available in Ontario, Nova Scotia, Newfoundland and Labrador, Alberta, British Columbia, Saskatchewan, Nunavut, New Brunswick, Quebec and Manitoba. SOURCE Rocky Health View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store